-
Medical journals
- Career
Articles on this topicDiabetes
How to Set Individual Treatment Goals for Type 2 Diabetes?
Treatment goals for type 2 diabetes should always be set individually. In practice, this…28. 8. 2020 Source: Diabetes
DPP-4 Inhibitors May Prevent SARS-CoV-2 Entry into Cells
Since the new type of coronavirus SARS-CoV-2 utilizes the DPP-4 receptor to enter human cells,…3. 8. 2020 Source: Diabetes
Algorithm for Choosing Antidiabetics in Patients with Type 2 Diabetes
As of June 1, 2020, general practitioners can prescribe antidiabetics from the group of…29. 7. 2020 Source: Diabetes
How to Improve Diabetic Adherence?
The dream of every doctor is a conscientious patient who follows the prescribed treatment and reports...7. 5. 2020 Source: Diabetes
Impact of Empagliflozin on the Risk of Cardiovascular Death and Need for Hospitalization Due to Heart Failure
In the EMPA-REG OUTCOME study, empagliflozin reduced the risk of cardiovascular death and the number...10. 4. 2020 Source: Diabetes
Mechanisms Connecting Diabetes Mellitus and Obesity
Obesity has a close relationship with insulin resistance and diabetes mellitus (DM); weight gain...29. 3. 2020 Source: Diabetes
Combination of SGLT2 inhibitors with metformin in terms of mechanism of action
In the treatment of type 2 diabetes (T2D), metformin is recommended as the first-line drug alongside...18. 3. 2020 Source: Diabetes
Favorable effect of linagliptin on renal endothelial functions in patients with type 2 diabetes mellitus
Diabetic nephropathy is the cause of up to 50% of cases of end-stage chronic kidney disease. The...1. 3. 2020 Source: Diabetes
Regular Walking as an Intervention to Support the Quality of Life of Diabetics
Diabetes mellitus (DM), as a chronic and in many cases disabling disease, limits patients in various...25. 2. 2020 Source: Diabetes
Documented Cardiovascular Benefit of Empagliflozin in New American Diabetes Treatment Guidelines
Two leading overseas medical professional societies, the American Diabetes Association (ADA) and...14. 2. 2020 Source: Diabetes
Cardiovascular Benefit of SGLT2 Inhibitors Confirmed
The cardiovascular (CV) benefit of SGLT2 inhibitors in type 2 diabetics, demonstrated by empagliflozin...31. 1. 2020 Source: Diabetes
Impact of Oral Antidiabetics on Heart Failure
Diabetes mellitus is primarily perceived as a risk factor for ischemic heart disease and general...19. 1. 2020 Source: DiabetesJournal articles Type 1 and 2 diabetes and pregnancy
23. 7. 2010 Source: Practical Gynecology | 2/2010Journal articles Type 2 diabetes mellitus in old age
26. 6. 2014 Source: Geriatrics and Gerontology | 2/2014
LoginSubscribe
E-courses on this topic
Course detailAuthors: Prof. MUDr. Martin Haluzík, DrSc., prof. MUDr. Vojtěch Melenovský, CSc., prof. MUDr. Vladimír Tesař, DrSc.
Most read on this topic- 10 Properties and Benefits of Gliptins: How They Work and When to Prescribe Them
- How Diabetes Shortens Life or Mortality of Patients with Type 2 Diabetes
- Gliflozins in the Treatment of Type 2 Diabetes According to Current Recommendations SVL
- What a General Practitioner Needs to Know About Gliflozins
- Prescription Restrictions on Antidiabetics Authorized for Prescription by General Practitioners - Status as of October 2020
- Mechanisms Connecting Diabetes Mellitus and Obesity
Journal on this topic
Related topicLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career